MDT

97.25

+1.88%↑

VEEV

300.62

+4.11%↑

139.72

-0.04%↓

HQY

90.34

-0.32%↓

PHR.US

23.41

+5.4%↑

MDT

97.25

+1.88%↑

VEEV

300.62

+4.11%↑

139.72

-0.04%↓

HQY

90.34

-0.32%↓

PHR.US

23.41

+5.4%↑

MDT

97.25

+1.88%↑

VEEV

300.62

+4.11%↑

139.72

-0.04%↓

HQY

90.34

-0.32%↓

PHR.US

23.41

+5.4%↑

MDT

97.25

+1.88%↑

VEEV

300.62

+4.11%↑

139.72

-0.04%↓

HQY

90.34

-0.32%↓

PHR.US

23.41

+5.4%↑

MDT

97.25

+1.88%↑

VEEV

300.62

+4.11%↑

139.72

-0.04%↓

HQY

90.34

-0.32%↓

PHR.US

23.41

+5.4%↑

Home・Aktien・NeoGenomics Inc

NeoGenomics Inc

Open

8.98 5.77

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

8.29

Max

9.07

Schlüsselkennzahlen
By Trading Economics
Einkommen	-19M -45M
Verkäufe	13M 181M
Gewinnspanne	-24.867
Angestellte	2,200
EBITDA	-41M -48M

Empfehlungen
By TipRanks
Empfehlungen	Buy
12-Monats-Prognose	+22.36% upside

Dividenden
By Dow Jones
Nächstes Ergebnis	4. Nov. 2025

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	172M 1B
Vorheriger Eröffnungskurs	3.21
Vorheriger Schlusskurs	8.98

Technischer Score

By Trading Central

Vertrauen

Very Strong Bearish Evidence

7.7 / 10.27 Unterstützung & Widerstand

NeoGenomics Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

30. Sept. 2025, 14:35 UTC

Wichtige Markttreiber

Robo.ai Shares Rise After $300 Million Investment From Burkhan Capital

25. Sept. 2025, 16:56 UTC

Wichtige Markttreiber

PSQ Holdings Stock Slides on Plans to Launch Crypto Treasury Service

25. Sept. 2025, 16:31 UTC

Wichtige Markttreiber

SharpLink Gaming Shares Fall on Plan to Tokenize Stock

25. Sept. 2025, 08:03 UTC

Wichtige Markttreiber

Naver Surges on Talks With Cryptocurrency-Exchange Operator

23. Sept. 2025, 18:02 UTC

Wichtige Markttreiber

Super League Shares Double After $10 Million Equity Investment From Evo Fund

23. Sept. 2025, 13:09 UTC

Akquisitionen, Fusionen, Übernahmen

Innovation Beverage Strikes Deal to Merge Into BlockFuel Energy

22. Sept. 2025, 17:33 UTC

Wichtige Markttreiber

AgriFORCE Growing Systems Shares Double on New Blockchain Strategy

2. Okt. 2025, 13:17 UTC

Akquisitionen, Fusionen, Übernahmen

Bitcoin Depot: Acquisition Had No Material Impact on Reported 3Q Preliminary Results >BTM

2. Okt. 2025, 13:16 UTC

Akquisitionen, Fusionen, Übernahmen

Bitcoin Depot: Acquisition Brings U.S. Market Share to Roughly 30% >BTM

2. Okt. 2025, 13:16 UTC

Akquisitionen, Fusionen, Übernahmen

Bitcoin Depot: Acquisition Adds Over 500 Kiosks to Network >BTM

2. Okt. 2025, 13:15 UTC

Akquisitionen, Fusionen, Übernahmen

Bitcoin Depot Acquires Assets of National Bitcoin ATM, Significantly Expanding U.S. Footprint

2. Okt. 2025, 07:05 UTC

Market Talk

Global Equities Roundup: Market Talk

2. Okt. 2025, 07:05 UTC

Market Talk

Bitcoin Rises Following Wall Street Rally -- Market Talk

1. Okt. 2025, 23:12 UTC

Akquisitionen, Fusionen, Übernahmen

Avalanche Treasury CEO is Bart Smith

1. Okt. 2025, 23:11 UTC

Akquisitionen, Fusionen, Übernahmen

Avalanche Treasury Investors Include Dragonfly, VanEck, Galaxy Digital and Others

1. Okt. 2025, 23:07 UTC

Akquisitionen, Fusionen, Übernahmen

Avalanche Treasury Plans to Own More Than $1B Worth of AVAX After Becoming a Public Company

1. Okt. 2025, 23:06 UTC

Akquisitionen, Fusionen, Übernahmen

Avalanche Treasury Co. Has an Exclusive Relationship With Avalanche Foundation

1. Okt. 2025, 23:04 UTC

Akquisitionen, Fusionen, Übernahmen

Avalanche Treasury: Transaction Includes About $460M in Treasury Assets

1. Okt. 2025, 14:01 UTC

Market Talk

Bitcoin Rises as Weak Jobs Data Boost Rate-Cut Bets -- Market Talk

1. Okt. 2025, 07:27 UTC

Market Talk

Bitcoin Edges Lower as U.S. Government Shut Down Begins -- Market Talk

30. Sept. 2025, 14:20 UTC

Wichtige Markttreiber

Robo.ai Shares Rise After $300M Investment From Burkhan Capital

30. Sept. 2025, 06:51 UTC

Market Talk

Bitcoin Eases as Possible U.S. Government Shutdown Looms -- Market Talk

29. Sept. 2025, 13:48 UTC

Market Talk

Seasonality Could Favor Bitcoin in Coming Months -- Market Talk

29. Sept. 2025, 07:40 UTC

Market Talk

Bitcoin Recovers But Remains at Risk of Renewed Losses -- Market Talk

26. Sept. 2025, 07:29 UTC

Market Talk

Bitcoin Stabilizes After Steep Falls; Focus Turns to U.S. PCE Data -- Market Talk

25. Sept. 2025, 09:16 UTC

Market Talk

Bitcoin Falls as Investors Await U.S. Data -- Market Talk

24. Sept. 2025, 12:50 UTC

Akquisitionen, Fusionen, Übernahmen

Fitell Corp Completes Initial $10M Solana Purchase Following the First Closing Under $100M Financing Facility

24. Sept. 2025, 06:55 UTC

Market Talk

Bitcoin Stays Weak After Powell Remarks -- Market Talk

23. Sept. 2025, 17:47 UTC

Wichtige Markttreiber

Super League Shares Double After $10M Equity Investment From Evo Fund

22. Sept. 2025, 20:36 UTC

Akquisitionen, Fusionen, Übernahmen

Scaramucci-Backed Crypto Treasury Company Launches With $550 Million Fundraising Plan -- Update

Peer-Vergleich

Kursveränderung

NeoGenomics Inc Prognose

Kursziel

By TipRanks

22.36% Vorteil

12-Monats-Prognose

Durchschnitt 10.67 USD 22.36%

Hoch 14 USD

Tief 8 USD

Basierend auf 11 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für NeoGenomics Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

11 ratings

Buy

Halten

Sell

Basierend auf 11 Analysten, die in den letzten 3 Monaten Aktienbewertungen für NeoGenomics Inc – Dist abgegeben haben.

Technischer Score

By Trading Central

7.7 / 10.27Unterstützung & Widerstand

Recent bearish events outweigh bullish events.

All events are bearish.

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.